Aims-To investigate whether proteogly-
The possible role of extracellular matrix (ECM) components in some neurological diseases, including Alzheimer's disease, has come under increasing scrutiny."2 In Alzheimer's disease several proteoglycans and ECM molecules have been associated with neuritic plaques.2
The direct interaction of heparan sulphate proteoglycans with the P-amyloid precursor protein (n-APP), an essential component of neuritic plaques, has been shown in vitro5 and in vivo6 after infusions of 3-APP plus a specific heparan sulphate proteoglycan. This suggests that heparan sulphate proteoglycans are key elements in the formation of the amyloid plaques that are characteristic of Alzheimer's disease, providing that the nucleation events, needed for facilitation of protein conformations, induce fibril formation and/or decrease amyloid susceptibility to proteolysis. Changes in proteoglycan synthesis may promote neurofibrillary tangles and cerebrovascular amyloid deposition.
On the other hand, several biochemical changes in non-neuronal tissue have been shown in Alzheimer's disease. 9 Cultured fibroblasts from familial Alzheimer's disease were less able to adhere to substrata than agematched healthy control fibroblasts.' " The cell adhesion process is the result of several interactions between molecules present at the cell surface and in the ECM; among the cell surface receptors, integrins and proteoglycans are the most well known,1>14 whereas molecules in the ECM, such as laminin, fibronectin, and several types of proteoglycans, have been reported to participate in the adhesion process.'5 A previous report evaluated the proteoglycan composition of isolated fibroblasts from Alzheimer's disease and found a small increase in sulphate incorporation into proteoglycans compared with normal controls."' However, the analysis was mainly focused on glycosaminoglycan (GAG) composition rather than the characteristics of intact proteoglycans. Therefore, we decided to evaluate and characterise the proteoglycans synthesised and secreted by fibroblasts from patients with Alzheimer's disease, and to compare the findings with those from healthy controls.
Methods
The following material were purchased: Na2f5SO4 carrier free was obtained from New brain tissue by the presence of Alzheimer's disease plaques. All the cell lines used presented a normal diploid karyotype. Cells were studied at passage 10 through 14. Previous studies have indicated that Alzheimer's disease fibroblasts do not age in culture more rapidly than cells from age-matched controls.'7 Fibroblasts were twice cultured in Eagle's minimum essential medium with essential and non-essential vitamins and amino acids, 15% fetal calf serum, penicillin (100 U/ml) and streptomycin (100 jg/ml). PROTEOGLYCAN LABELLING Dishes 80 cm2 containing a confluent monolayer of each cell line and seeded at a constant density of 1 x 104 cells/cm2 9 1 for six hours,'0 " were radiolabelled in the presence of 10 iCi/ml of 35S-sulphate for 18 hours. The medium was removed and dialysed with 2 litres of 10 mM TRIS-HCl, pH 7,4, 0.1 M NaCl, including protease inhibitors at 4°C. The samples were concentrated in a Amicon filtration system and separated on SDS-PAGE and exposed to x-ray film, as described before.'9 The recovery of the sulphated material after dialysis and concentration ranged between 80 and 87%. Chondroitinase ABC, AC, and heparitinase treatments of labelled proteoglycans obtained from the cell cultures were done exactly as described before.20 Glypican was determined after release from the fibroblast surface by phosphatidylinositol-specific phospholipase C (PI-PLC), as described before.20
GEL FILTRATION CHROMATOGRAPHY
The radiolabelled samples were concentrated in a small DEAE-Sephacel column equilibrated in the above buffer; bound material was eluted with the same buffer containing 1.0 M NaCl and then fractionated on analytical Sepharose CL-6B (1.0 x 100 cm) prepared in 1 % SDS, 0.1 M NaCl, and 50 mM TRIS-HCl buffer, pH 8.0. Samples (0.5 ml) were applied to the column together with previously fractionated Blue Dextran (2000) and Phenol Red, to mark void and total volumes, respectively. Columns were eluted at a flow rate of 5.0 ml/hour and effluent fractions of 1.0 ml were collected and counted for radioactivity.
WESTERN BLOT ANALYSIS
Incubation medium obtained from normal and Alzheimer's disease fibroblasts was concentrated in Amicon and incubated with chondroitinase ABC, followed by electrophoresis on 8% polyacrylamide gel; proteins were transferred to nitrocellulose, incubated in Blotto (20 mM TRIS-HCl, pH 7.4, 0.1 M NaCl, 5% non-fat dry milk) at room temperature to block non-specific binding, and incubated with rabbit anti-decorin antiserum (1 in 100 dilution in Blotto).21 The bound antibody was visualised with affinity purified phosphatase alkaline conjugated goat anti-rabbit IgG. Thus the 280-220 kilodalton proteoglycan corresponds to biglycan whereas the 150-125 kilodalton corresponds to decorin. The same result was observed in proliferating fibroblasts, suggesting that the decrease observed in the amount of decorin is independent of the proliferative state of the cells.
To confirm that the synthesis of decorin was diminished in Alzheimer's disease fibroblasts, we determined the amount of decorin in the incubation media from normal and Alzheimer's disease fibroblasts. Samples were concentrated and separated on SDS-PAGE after chondroitinase ABC treatment. The separated proteins were transferred to a nitrocellulose membrane and incubated with antiserum against rat decorin, followed by a second antibody conjugated with alkaline phosphatase to reveal the core protein. Figure 3 (lane 1) shows that normal fibroblasts synthesise and secrete a much higher decorin concentration than Alzheimer's disease fibroblasts (lane 2 Decorin is a proteoglycan present in the ECM of several tissues, including blood vessel walls, tendon, sclera, skeletal muscle as well as other interstitial tissues.'9 22 26 Decorin can interact with several ECM molecules, such as collagen types I, Vl, and XIV, fibronectin, and transforming growth factor-5 (TGF-[), [27] [28] [29] [30] suggesting that this proteoglycan is a key molecule for ECM organisation and for the binding and/or presentation of soluble factors to the cell. The adhesion of Alzheimer's disease fibroblasts from patients with familiar Alzheimer's disease is significantly suppressed compared with age-matched controls.'01 Because there are multiple binding sites for ECM molecules present on the decorin molecule, an altered ECM could receive deposits from the Alzheimer's disease fibroblasts, which would affect the normal interaction with the ECM receptors on the cell surface.'2 14 Furthermore, in those experiments where adhesion of the fibroblasts was reduced, changes in the arrangement of cytoskeletal vimentin were also observed.' " Because changes in the expression of surface proteoglycans strongly influence cytoskeletal organisation,3' altered synthesis of decorin, as shown in this study, may directly affect the interaction between the cell and the ECM, changing the intracellular arrangement of the cytoskeleton and therefore cellular behaviour. On the other hand, decorin can bind soluble factors such TGF-j, regulating their biological activity..... The diminished expression of decorin in Alzheimer's disease fibroblasts might have a strong effect on the interaction between the cell and the ECM. It would be interesting to determine whether the addition of purified decorin to these cells enhanced the adhesion phenomena. Because decorin has multiple functions, it would be intriguing to investigate whether the characteristics of the skin of Alzheimer's disease patients shows some degree of alteration. Experiments to determine the organisation of the skin as well decorin concentrations and/or their transcripts would be worth doing on skin from Alzheimer's disease patients. If such a change is observed it would be essential to determine when these alterations began and to understand whether these parallel the onset of the disease.
Apart from the possible consequences on fibroblast adhesion, as a result of altered proteoglycan synthesis, proteoglycans have a direct role in the formation of the typical amyloid containing plaques and neurofibrillary tangles in Alzheimer's disease. Decorin has been demonstrated in the periphery of amyloid containing plaques and neurofibrillary tangles of 
